Table 2 Clinicopathological status of breast cancer and immunohistochemical staining (IHC).
Characteristic | Total | TFF1 | TFF1 P value | TFF3 | TFF3 P value |
|---|---|---|---|---|---|
Age (years, mean ± SD) | 54 ± 12.3 |  |  |  |  |
Sex | |||||
  Women | 46 |  |  |  |  |
Histological type | Â | Â | 0.456 | Â | 0.614 |
  DCIS | 5 | 1.8 ± 0.8 |  | 2.4 ± 0.9 |  |
  IDC | 35 | 1.3 ± 1.0 |  | 2.0 ± 1.0 |  |
  Others | 6 | 1.7 ± 1.0 |  | 2.3 ± 1.0 |  |
Tumor size | Â | Â | 0.534 | Â | 0.793 |
  >2 cm | 17 | 1.5 ± 0.9 |  | 2.1 ± 1.0 |  |
  ≤2 cm | 29 | 1.3 ± 1.0 |  | 2.1 ± 1.0 |  |
Nodal status (missing 3) | Â | Â | 0.102 | Â | 0.904 |
  pN− | 29 | 1.2 ± 0.8 |  | 2.1 ± 1.0 |  |
  pN+ | 14 | 1.7 ± 1.1 |  | 2.1 ± 1.0 |  |
Nuclear grade (missing 6) | Â | Â | 0.917 | Â | 0.610 |
  I | 25 | 1.4 ± 0.9 |  | 2.0 ± 1.0 |  |
  II | 5 | 1.2 ± 1.1 |  | 1.8 ± 1.1 |  |
  III | 10 | 1.4 ± 1.3 |  | 2.3 ± 1.1 |  |
Lymphatic vessel invasion | Â | Â | 0.305 | Â | 0.205 |
  Negative | 34 | 1.5 ± 0.9 |  | 2.0 ± 1.0 |  |
  Positive | 12 | 1.2 ± 1.1 |  | 2.4 ± 0.9 |  |
Vascular invasion | Â | Â | 0.719 | Â | 0.564 |
  Negative | 34 | 1.4 ± 0.9 |  | 2.1 ± 1.0 |  |
  Positive | 12 | 1.5 ± 1.1 |  | 2.3 ± 0.9 |  |
ER (missing 1) | Â | Â | 0.109 | Â | 0.836 |
  Negative | 6 | 0.8 ± 0.8 |  | 2.2 ± 1.0 |  |
  Positive | 39 | 1.5 ± 1.0 |  | 2.1 ± 1.0 |  |
PR (missing 2) | Â | Â | 0.011 | Â | 0.793 |
  Negative | 7 | 0.6 ± 0.5 |  | 2.0 ± 1.3 |  |
  Positive | 37 | 1.6 ± 1.0 |  | 2.1 ± 0.9 |  |
HER2 (missing 6) | Â | Â | 0.182 | Â | 0.342 |
  Negative | 36 | 1.4 ± 1.0 |  | 2.0 ± 1.0 |  |
  Positive | 4 | 0.8 ± 0.5 |  | 2.5 ± 1.0 |  |
Ki67 (missing 7) | Â | Â | 0.059 | Â | 0.650 |
  <30% | 28 | 1.5 ± 0.9 |  | 2.1 ± 1.0 |  |
  ≥30% | 11 | 1.3 ± 1.0 |  | 1.9 ± 1.0 |  |
Subtype (missing 7) | Â | Â | 0.067 | Â | 0.253 |
  LuminalA | 25 | 1.7 ± 0.9 |  | 2.0 ± 1.0 |  |
  LuminalB | 10 | 1.0 ± 0.9 |  | 2.0 ± 1.1 |  |
  HER2 type | 2 | 0.5 ± 0.7 |  | 3.0 ± 0 |  |
  Triple negative | 2 | 0.5 ± 0.7 |  | 1.0 ± 0 |  |
